SiRNA targeting hepatoma-derived growth factor (HDGF) inhibits growth of non-small cell lung cancer in xenograft models.

被引:0
|
作者
Zhang, Jun
Mao, Li
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
[2] China Med Univ, Dept Thorac Surg, Clin Coll 1, Shenyang, Liaoning, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5135
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Downregulation of miR-497 promotes tumor growth and angiogenesis by targeting HDGF in non-small cell lung cancer.
    Zhao, Wen-yan
    Wang, Yan
    An, Zhong-jun
    Shi, Chang-guo
    Zhu, Guang-ai
    Wang, Bin
    Lu, Ming-yan
    Pan, Chang-kun
    Chen, Peng
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 435 (03) : 466 - 471
  • [42] Circulating auto-antibody against hepatoma-derived growth factor (HDGF) in patients with ulcerative colitis
    Nakamura, H
    Yoshida, K
    Kishima, Y
    Enomoto, H
    Uyama, H
    Okuda, TKY
    Hirotani, T
    Ito, H
    Kawase, I
    HEPATO-GASTROENTEROLOGY, 2004, 51 (56) : 470 - 475
  • [43] COMBINED TARGETING OF AROMATASE AND EPIDERMAL GROWTH FACTOR RECEPTOR IN NON-SMALL CELL LUNG CANCER
    Kritikou, I.
    Giannopoulou, E.
    Koutras, A. K.
    Kalofonos, H.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S41 - S41
  • [44] Targeting oncogenic KRAS in non-small cell lung cancer cells by phenformin inhibits growth and angiogenesis
    Wang, Zhi Dong
    Wei, Sheng Quan
    Wang, Qin Yi
    AMERICAN JOURNAL OF CANCER RESEARCH, 2015, 5 (11): : 3339 - +
  • [45] Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer
    Uyama, Hirokazu
    Tomita, Yasuhiko
    Nakamura, Hideji
    Nakamori, Shoji
    Zhang, Binglin
    Hoshida, Yoshihiko
    Enomoto, Hirayuki
    Okuda, Yorihide
    Sakon, Masato
    Aozasa, Katsuyuki
    Kawase, Ichiro
    Hayashi, Norio
    Monden, Morito
    CLINICAL CANCER RESEARCH, 2006, 12 (20) : 6043 - 6048
  • [46] Platelet derived growth factor receptors regulated microRNAs in non-small cell lung cancer
    Naidu, S.
    Garofalo, M.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S187 - S187
  • [47] Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small cell lung cancer
    O'Byrne, KJ
    Koukourakis, MI
    Giatromanolaki, A
    Cox, G
    Turley, H
    Steward, WP
    Gatter, K
    Harris, AL
    BRITISH JOURNAL OF CANCER, 2000, 82 (08) : 1427 - 1432
  • [48] Oncogenic actions of HDGF (hepatoma-derived growth factor) in colorectal cancer: implication for tumor biology/patient prognosis and modulation by butyrate
    Melcher, R.
    Kudlich, T.
    Rogoll, D.
    Grell, A.
    Neun, T.
    Wilk, M.
    Luehrs, H.
    Einsele, H.
    Scheurlen, M.
    ONKOLOGIE, 2012, 35 : 55 - 55
  • [49] Hepatoma-derived growth factor expression as a prognostic marker in cervical cancer
    Misa Song
    Miki Tomoeda
    Yu-Feng Jin
    Chiaki Kubo
    Hidenori Yoshizawa
    Masanori Kitamura
    Shigenori Nagata
    Yukinobu Ohta
    Shoji Kamiura
    Hideji Nakamura
    Yasuhiko Tomita
    World Journal of Obstetrics and Gynecology, 2015, 4 (01) : 16 - 23
  • [50] Inhibition of angiogenesis and tumor growth by itraconazole in primary xenograft models of human non-small cell lung cancer
    Aftab, Blake T.
    Dobromilskaya, Irina
    Hann, Christine L.
    Liu, Jun O.
    Rudin, Charles M.
    CANCER RESEARCH, 2011, 71